Cenlub Industrie (522251)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 20.47% indicates decent capital efficiency and possible pricing power in its niche.
• P/E of 13.25 is not extreme on trailing earnings for a small-cap industrial.
• Book value of ₹140.86 per share provides some asset backing; P/B of 2.55 is not absurd.
• Latest quarter still shows positive sales of ₹16 Cr and net profit of ₹1 Cr, no outright loss.

Concerns

• Profit growth down 44.85% and sales down 4.67% show clear business contraction.
• Latest quarter net profit of ₹1 Cr annualizes to only ~₹4 Cr, far below the ~₹12.6 Cr implied by the current P/E.
• Piotroski F-Score of 3/9 points to deteriorating financial health and weak operating momentum.
• Zero dividend yield and a 52-week high price of ₹359.10 suggest the rally is running ahead of fundamentals.

AI Analysis

Let's start with what I see. Cenlub Industrie is a small industrial products company with a market cap of ₹167 crore. At ₹359.10, it sells at a P/E of 13.25 and 2.55 times book. On the surface, that does not look outrageous. But I don't buy surface. I want a business that can generate consistent returns. Here, returns are not awful—ROE is 11.94% and ROCE is 20.47%, suggesting the underlying capital allocation has historically been decent. However, the recent trajectory is troubling. Sales fell 4.67% and profits collapsed 44.85%. The latest quarter makes the damage even clearer: sales of ₹16 crore, but net profit of only ₹1 crore. That is roughly a 6% margin, and annualized earnings would be only about ₹4 crore, not the ₹12.6 crore the trailing P/E implies. The Piotroski F-Score of 3 out of 9 also tells me the financial health is deteriorating, not improving. The stock is at its 52-week high of ₹359.10, more than 2.6 times its low of ₹137.00. Prices have run far ahead of fundamentals. With zero dividend yield, the only returns come from price appreciation and reinvested earnings—and right now earnings are shrinking. Graham would ask: where is the margin of safety? At 2.55 times book, for a company with declining profit and no dividend, I don't find it. The positive ROCE gives hope, but hope is not a strategy. This looks like a cyclical industrial name caught in an earnings downcycle, and the market is anticipating a recovery. I need evidence of recovery—stable quarterly profit, positive F-score, better sales—before I trust this rally. For now, it's in the 'too hard' pile, or at least on a very short leash.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer